Caroline Bhatt

Caroline Bhatt investigates how AI can accelerate clinical trial design and drug development in oncology. Her research applies natural language processing to clinical trial literature, machine learning to biomarker discovery for patient stratification, and predictive modeling for trial outcome simulation. She develops AI-assisted adaptive trial design tools and investigates how digital biomarkers from wearable sensors can augment traditional endpoints. Her work aims to reduce time-to-approval for novel cancer drugs through intelligent trial design and monitoring.